$WST
WEST PHARMACEUTICAL SERVICES INC

2020 Q4 Form 10-Q Financial Statement

#000010577020000057 Filed on October 23, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $580.2M $548.0M $456.1M
YoY Change 23.29% 20.15% 5.65%
Cost Of Revenue $369.1M $353.4M $308.3M
YoY Change 16.29% 14.63% 4.12%
Gross Profit $211.1M $194.6M $147.8M
YoY Change 37.79% 31.66% 9.0%
Gross Profit Margin 36.38% 35.51% 32.41%
Selling, General & Admin $76.30M $76.20M $64.80M
YoY Change 10.58% 17.59% -0.15%
% of Gross Profit 36.14% 39.16% 43.84%
Research & Development $12.90M $12.50M $9.300M
YoY Change 26.47% 34.41% -7.92%
% of Gross Profit 6.11% 6.42% 6.29%
Depreciation & Amortization $28.50M $28.40M $25.30M
YoY Change 8.37% 12.25% -3.44%
% of Gross Profit 13.5% 14.59% 17.12%
Operating Expenses $91.40M $88.70M $74.10M
YoY Change 23.51% 19.7% -1.2%
Operating Profit $119.7M $99.20M $67.30M
YoY Change 51.14% 47.4% 10.69%
Interest Expense -$4.900M $2.100M $2.100M
YoY Change 512.5% 0.0% 5.0%
% of Operating Profit -4.09% 2.12% 3.12%
Other Income/Expense, Net $900.0K -$1.500M -$1.300M
YoY Change 800.0% 15.38% -172.22%
Pretax Income $115.1M $97.70M $64.90M
YoY Change 48.71% 50.54% 6.22%
Income Tax $20.40M $21.10M $10.90M
% Of Pretax Income 17.72% 21.6% 16.8%
Net Earnings $98.40M $82.30M $56.30M
YoY Change 53.99% 46.18% 1.99%
Net Earnings / Revenue 16.96% 15.02% 12.34%
Basic Earnings Per Share $1.32 $1.11 $0.76
Diluted Earnings Per Share $1.29 $1.09 $0.75
COMMON SHARES
Basic Shares Outstanding 73.93M shares 73.90M shares 74.00M shares
Diluted Shares Outstanding 75.80M shares 75.50M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $615.5M $519.4M $396.0M
YoY Change 40.17% 31.16% 33.2%
Cash & Equivalents $615.5M $519.4M $396.0M
Short-Term Investments
Other Short-Term Assets $51.60M $51.00M $61.60M
YoY Change -20.12% -17.21% 42.92%
Inventory $321.3M $294.9M $230.4M
Prepaid Expenses
Receivables $385.3M $373.0M $316.1M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.374B $1.238B $1.004B
YoY Change 29.75% 23.32% 18.12%
LONG-TERM ASSETS
Property, Plant & Equipment $943.2M $883.4M $812.1M
YoY Change 12.38% 8.78% -1.2%
Goodwill $111.1M $109.3M $106.6M
YoY Change 3.06% 2.53% 0.28%
Intangibles $30.50M $30.60M $28.70M
YoY Change 2.35% 6.62% 36.67%
Long-Term Investments $201.9M $194.2M $84.00M
YoY Change 12.6% 131.19% 8.95%
Other Assets $23.40M $21.80M $20.00M
YoY Change -5.26% 9.0% -7.83%
Total Long-Term Assets $1.420B $1.345B $1.170B
YoY Change 10.71% 14.92% 6.74%
TOTAL ASSETS
Total Short-Term Assets $1.374B $1.238B $1.004B
Total Long-Term Assets $1.420B $1.345B $1.170B
Total Assets $2.794B $2.583B $2.174B
YoY Change 19.32% 18.8% 11.71%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $213.1M $180.3M $145.3M
YoY Change 35.91% 24.09% 16.05%
Accrued Expenses $118.4M $108.2M $84.60M
YoY Change 39.62% 27.9% 21.73%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.300M $2.300M $0.00
YoY Change 0.0%
Total Short-Term Liabilities $503.4M $447.7M $335.0M
YoY Change 47.37% 33.64% 16.0%
LONG-TERM LIABILITIES
Long-Term Debt $252.9M $253.4M $195.1M
YoY Change -0.82% 29.88% -0.56%
Other Long-Term Liabilities $31.80M $46.80M $35.70M
YoY Change 35.9% 31.09% -18.49%
Total Long-Term Liabilities $284.7M $300.2M $230.8M
YoY Change 2.26% 30.07% -3.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $503.4M $447.7M $335.0M
Total Long-Term Liabilities $284.7M $300.2M $230.8M
Total Liabilities $939.3M $863.9M $686.4M
YoY Change 22.27% 25.86% 15.5%
SHAREHOLDERS EQUITY
Retained Earnings $1.847B $1.773B $1.497B
YoY Change 19.19% 18.44% 14.06%
Common Stock $18.80M $18.80M $18.80M
YoY Change 0.0% 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $167.7M $182.0M $126.6M
YoY Change 42.0% 43.76% 16.47%
Treasury Stock Shares 1.300M shares 1.400M shares 1.300M shares
Shareholders Equity $1.855B $1.719B $1.488B
YoY Change
Total Liabilities & Shareholders Equity $2.794B $2.583B $2.174B
YoY Change 19.32% 18.8% 11.71%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income $98.40M $82.30M $56.30M
YoY Change 53.99% 46.18% 1.99%
Depreciation, Depletion And Amortization $28.50M $28.40M $25.30M
YoY Change 8.37% 12.25% -3.44%
Cash From Operating Activities $148.7M $118.6M $108.1M
YoY Change 39.76% 9.71% 22.29%
INVESTING ACTIVITIES
Capital Expenditures $53.90M $47.50M $31.70M
YoY Change 43.35% 49.84% 19.62%
Acquisitions
YoY Change
Other Investing Activities -$3.700M -$1.600M $100.0K
YoY Change -95.54% -1700.0%
Cash From Investing Activities -$57.60M -$49.10M -$31.60M
YoY Change -52.24% 55.38% 19.25%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -8.700M -7.200M -400.0K
YoY Change -117.06% 1700.0% -103.96%
NET CHANGE
Cash From Operating Activities 148.7M 118.6M 108.1M
Cash From Investing Activities -57.60M -49.10M -31.60M
Cash From Financing Activities -8.700M -7.200M -400.0K
Net Change In Cash 82.40M 62.30M 76.10M
YoY Change 123.91% -18.13% 5.69%
FREE CASH FLOW
Cash From Operating Activities $148.7M $118.6M $108.1M
Capital Expenditures $53.90M $47.50M $31.70M
Free Cash Flow $94.80M $71.10M $76.40M
YoY Change 37.79% -6.94% 23.42%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0000105770
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-8036
dei Entity Registrant Name
EntityRegistrantName
WEST PHARMACEUTICAL SERVICES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
PA
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
23-1210010
dei Entity Address Address Line1
EntityAddressAddressLine1
530 Herman O. West Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Exton
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19341-0645
dei City Area Code
CityAreaCode
610
dei Local Phone Number
LocalPhoneNumber
594-2900
dei Security12b Title
Security12bTitle
Common Stock, par value $0.25 per share
dei Trading Symbol
TradingSymbol
WST
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
73927188 shares
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
548000000.0 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
456100000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
194600000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1566700000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1369300000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
353400000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
308300000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1010000000.0 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
916800000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
147800000 USD
us-gaap Gross Profit
GrossProfit
556700000 USD
us-gaap Gross Profit
GrossProfit
452500000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12500000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9300000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34000000.0 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28700000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
76200000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
64800000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
225700000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
203700000 USD
CY2020Q3 wst Other Income Expense
OtherIncomeExpense
-6700000 USD
CY2019Q3 wst Other Income Expense
OtherIncomeExpense
-6400000 USD
wst Other Income Expense
OtherIncomeExpense
-6200000 USD
wst Other Income Expense
OtherIncomeExpense
-1600000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
99200000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
67300000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
290800000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
218500000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
2100000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
2100000 USD
us-gaap Interest Expense
InterestExpense
6100000 USD
us-gaap Interest Expense
InterestExpense
6400000 USD
CY2020Q3 us-gaap Investment Income Net
InvestmentIncomeNet
200000 USD
CY2019Q3 us-gaap Investment Income Net
InvestmentIncomeNet
1000000.0 USD
us-gaap Investment Income Net
InvestmentIncomeNet
1200000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
2500000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
400000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1300000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
300000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-200000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
97700000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
64900000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
286200000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
214400000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21100000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10900000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
52100000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42500000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5700000 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2300000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
13700000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5900000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
82300000 USD
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74000000.0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73900000 shares
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
56300000 USD
us-gaap Net Income Loss
NetIncomeLoss
247800000 USD
us-gaap Net Income Loss
NetIncomeLoss
177800000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.11
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.76
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.40
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.09
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.28
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.36
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73900000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73900000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75800000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75600000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75300000 shares
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
82300000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
56300000 USD
us-gaap Net Income Loss
NetIncomeLoss
247800000 USD
us-gaap Net Income Loss
NetIncomeLoss
177800000 USD
CY2020Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
29400000 USD
CY2019Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-23800000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-4900000 USD
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-20100000 USD
CY2020Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-100000 USD
CY2019Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-700000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-1200000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansTaxPortionAttributableToParent
-700000 USD
CY2020Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
200000 USD
CY2019Q3 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-2400000 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
4000000.0 USD
us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
-2200000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
200000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
1500000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
400000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent
700000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-900000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
3200000 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-1000000.0 USD
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
1700000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
28300000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-18200000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-9900000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-16200000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
110600000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
38100000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
237900000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
373000000.0 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
319300000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
161600000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
519400000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
439100000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
294900000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
235700000 USD
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
51000000.0 USD
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
64600000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
1238300000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1058700000 USD
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1939100000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1820100000 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1055700000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
980800000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
883400000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
839300000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
67500000 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
30600000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
70100000 USD
CY2020Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
209600000 USD
CY2019Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
192700000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
109300000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
107800000 USD
CY2019Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
29800000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
22300000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
14000000.0 USD
CY2020Q3 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
0 USD
CY2019Q4 us-gaap Defined Benefit Plan Assets For Plan Benefits Noncurrent
DefinedBenefitPlanAssetsForPlanBenefitsNoncurrent
4300000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
21800000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
24700000 USD
CY2020Q3 us-gaap Assets
Assets
2582800000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
180300000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
156800000 USD
CY2019Q4 us-gaap Assets
Assets
2341400000 USD
CY2020Q3 us-gaap Debt Current
DebtCurrent
2300000 USD
CY2019Q4 us-gaap Debt Current
DebtCurrent
2300000 USD
CY2020Q3 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
2200000 USD
CY2019Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
2200000 USD
CY2020Q3 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
96100000 USD
CY2019Q4 us-gaap Other Employee Related Liabilities Current
OtherEmployeeRelatedLiabilitiesCurrent
73000000.0 USD
CY2020Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
30200000 USD
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6400000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9900000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9600000 USD
CY2020Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
126700000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
91300000 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
447700000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
341600000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
253400000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
255000000.0 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
4500000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
15500000 USD
CY2020Q3 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
51600000 USD
CY2019Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
52500000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
59900000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
62400000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
46800000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
41200000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
863900000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
768200000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000.0 shares
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
3000000.0 shares
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.25
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.25
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000.0 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000.0 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75300000 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
75300000 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
73900000 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
74100000 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
18800000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
18800000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
268200000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
272700000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1773400000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1549400000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-159500000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-149600000 USD
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
1400000 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1200000 shares
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
182000000.0 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
118100000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1718900000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1573200000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2582800000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2341400000 USD
us-gaap Net Income Loss
NetIncomeLoss
247800000 USD
us-gaap Net Income Loss
NetIncomeLoss
177800000 USD
us-gaap Depreciation
Depreciation
77300000 USD
us-gaap Depreciation
Depreciation
74600000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
3300000 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2500000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
27600000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
18800000 USD
us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
0 USD
us-gaap Restructuring Reserve Settled Without Cash2
RestructuringReserveSettledWithoutCash2
1600000 USD
wst Pension Settlement Charge
PensionSettlementCharge
3400000 USD
wst Pension Settlement Charge
PensionSettlementCharge
2700000 USD
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
700000 USD
us-gaap Payment For Contingent Consideration Liability Operating Activities
PaymentForContingentConsiderationLiabilityOperatingActivities
300000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
9500000 USD
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
600000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
25400000 USD
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
16300000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
323800000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
260800000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
116700000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
88800000 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
0 USD
us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
18900000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
3800000 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1400000 USD
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-300000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-121900000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-107400000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
28000000.0 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
0 USD
us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
28000000.0 USD
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
1700000 USD
us-gaap Repayments Of Other Long Term Debt
RepaymentsOfOtherLongTermDebt
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
900000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
35500000 USD
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
33300000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19700000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
25500000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
4600000 USD
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
4000000.0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
115500000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
83100000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-128400000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-87800000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6800000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-7000000.0 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
80300000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
58600000 USD
CY2019Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
600000 USD
CY2019Q2 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
18900000 USD
CY2019Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
4500000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
439100000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
337400000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
519400000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
396000000.0 USD
CY2019Q2 us-gaap Goodwill
Goodwill
2600000 USD
CY2019Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
11200000 USD
CY2020Q3 us-gaap Transfer Of Financial Assets Accounted For As Sales Cash Proceeds Received For Assets Derecognized Amount
TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount
8900000 USD
CY2019Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
9800000 USD
CY2020Q3 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
16200000 USD
wst Contract With Customer Asset Increase Decrease
ContractWithCustomerAssetIncreaseDecrease
6400000 USD
CY2019Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
34900000 USD
CY2020Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
56700000 USD
us-gaap Contract With Customer Liability Change In Timeframe Performance Obligation Satisfied Revenue Recognized
ContractWithCustomerLiabilityChangeInTimeframePerformanceObligationSatisfiedRevenueRecognized
-21800000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
23000000.0 USD
CY2019Q3 us-gaap Transfer Of Financial Assets Accounted For As Sales Cash Proceeds Received For Assets Derecognized Amount
TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount
7900000 USD
CY2018Q4 wst Provision For Product Returns
ProvisionForProductReturns
11300000 USD
CY2019Q3 wst Provision For Product Returns
ProvisionForProductReturns
900000 USD
wst Provision For Product Returns
ProvisionForProductReturns
4900000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
82300000 USD
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000 shares
CY2019Q4 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
848000 shares
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
56300000 USD
us-gaap Net Income Loss
NetIncomeLoss
247800000 USD
us-gaap Net Income Loss
NetIncomeLoss
177800000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73900000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
74000000.0 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73900000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73900000 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1900000 shares
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1500000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1700000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1400000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75800000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75500000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75600000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
75300000 shares
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0.0 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100000 shares
CY2020Q3 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
300000 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
761500 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
115500000 USD
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
151.65
CY2020Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
125400000 USD
CY2019Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
100900000 USD
CY2020Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
55800000 USD
CY2019Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
37400000 USD
CY2020Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
113700000 USD
CY2019Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
97400000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
294900000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
235700000 USD
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3100000 USD
CY2019Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
3400000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
9300000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
9700000 USD
CY2020Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
300000 USD
CY2019Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
100000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
600000 USD
us-gaap Short Term Lease Cost
ShortTermLeaseCost
500000 USD
CY2020Q3 us-gaap Variable Lease Cost
VariableLeaseCost
1200000 USD
CY2019Q3 us-gaap Variable Lease Cost
VariableLeaseCost
800000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
2800000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
2300000 USD
CY2020Q3 us-gaap Lease Cost
LeaseCost
4600000 USD
CY2019Q3 us-gaap Lease Cost
LeaseCost
4300000 USD
us-gaap Lease Cost
LeaseCost
12700000 USD
us-gaap Lease Cost
LeaseCost
12500000 USD
CY2020Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
3200000 USD
CY2019Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
3200000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
9600000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
9400000 USD
CY2020Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
300000 USD
CY2019Q3 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
300000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4600000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
8400000 USD
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y2M12D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P11Y8M12D
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0374
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0376
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
3400000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
12100000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
11800000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
10400000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
9700000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
8600000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
8700000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7800000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
8200000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
7300000 USD
CY2020Q3 wst Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
42600000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
41800000 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
84400000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
88000000.0 USD
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
14600000 USD
CY2019Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
16000000.0 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
69800000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
72000000.0 USD
CY2019Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
13400000 USD
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
194200000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
179300000 USD
CY2020Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
15400000 USD
CY2019Q4 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
85100000 USD
CY2019Q4 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
4900000 USD
CY2020Q3 wst Purchases And Royalty Payments From Equity Method Investees
PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
36600000 USD
wst Purchases And Royalty Payments From Equity Method Investees
PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
97000000.0 USD
CY2019Q3 wst Purchases And Royalty Payments From Equity Method Investees
PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
33000000.0 USD
wst Purchases And Royalty Payments From Equity Method Investees
PurchasesAndRoyaltyPaymentsFromEquityMethodInvestees
85200000 USD
CY2020Q3 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
28500000 USD
CY2019Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
20800000 USD
CY2020Q3 wst Sales To Equity Method Investees
SalesToEquityMethodInvestees
2700000 USD
wst Sales To Equity Method Investees
SalesToEquityMethodInvestees
7700000 USD
CY2019Q3 wst Sales To Equity Method Investees
SalesToEquityMethodInvestees
2200000 USD
wst Sales To Equity Method Investees
SalesToEquityMethodInvestees
6900000 USD
CY2020Q3 us-gaap Due From Affiliates
DueFromAffiliates
1700000 USD
CY2019Q4 us-gaap Due From Affiliates
DueFromAffiliates
1900000 USD
CY2020Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
256400000 USD
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
258000000.0 USD
CY2020Q3 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
700000 USD
CY2019Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
700000 USD
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
255700000 USD
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
257300000 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
2300000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
2300000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
253400000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
255000000.0 USD
CY2020Q3 us-gaap Gain Loss On Fair Value Hedges Recognized In Earnings
GainLossOnFairValueHedgesRecognizedInEarnings
1900000 USD
CY2019Q3 us-gaap Gain Loss On Fair Value Hedges Recognized In Earnings
GainLossOnFairValueHedgesRecognizedInEarnings
-4300000 USD
us-gaap Gain Loss On Fair Value Hedges Recognized In Earnings
GainLossOnFairValueHedgesRecognizedInEarnings
5900000 USD
us-gaap Gain Loss On Fair Value Hedges Recognized In Earnings
GainLossOnFairValueHedgesRecognizedInEarnings
5000000.0 USD
CY2020Q3 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
11200000 USD
CY2020Q3 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
1100000 USD
CY2020Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
12400000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
3500000 USD
CY2020Q3 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
12800000 USD
CY2020Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
34000000.0 USD
CY2019Q4 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
11300000 USD
CY2019Q4 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
7700000 USD
CY2019Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
19100000 USD
CY2019Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
3300000 USD
CY2019Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
12800000 USD
CY2019Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
17800000 USD
CY2018Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
1700000 USD
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-2100000 USD
CY2019 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
500000 USD
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3300000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-900000 USD
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
700000 USD
CY2020Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
3500000 USD
CY2020Q3 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
266400000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
253400000 USD
CY2019Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
263300000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
255000000.0 USD
us-gaap Oci Before Reclassifications Net Of Tax Attributable To Parent
OciBeforeReclassificationsNetOfTaxAttributableToParent
-8600000 USD
us-gaap Reclassification From Aoci Current Period Net Of Tax Attributable To Parent
ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent
1300000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-9900000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1573200000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
74300000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12800000 USD
CY2020Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
115500000 USD
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
11800000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-42700000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1490200000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
91200000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20400000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
4500000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1606300000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
82300000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
13900000 USD
CY2020Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2020Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
11900000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
28300000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1718900000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
1396300000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
55400000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10700000 USD
CY2019Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
83100000 USD
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
56300000 USD
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
10600000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
800000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
1369500000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
66100000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
19700000 USD
CY2019Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.15
CY2019Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
11400000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1200000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
1445100000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
16300000 USD
CY2019Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.16
CY2019Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
11900000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-18200000 USD
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
1487600000 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
1000000.0 USD
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10000000.0 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27600000 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2756301 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
230580 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
175.22
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
39.58
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.013
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M12D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.223
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.004
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5400000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
18800000 USD
CY2020Q3 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
400000 USD
CY2019Q3 us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
400000 USD
CY2020Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
1700000 USD
CY2019Q3 us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
2000000.0 USD
CY2020Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
2800000 USD
CY2019Q3 us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
3100000 USD
CY2020Q3 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
-100000 USD
CY2019Q3 us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
-100000 USD
CY2020Q3 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
200000 USD
CY2019Q3 us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
200000 USD
CY2020Q3 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-1100000 USD
CY2019Q3 us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-2700000 USD
CY2020Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
100000 USD
CY2019Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1700000 USD
CY2020Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
100000 USD
CY2019Q3 us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1700000 USD
us-gaap Defined Benefit Plan Service Cost
DefinedBenefitPlanServiceCost
1100000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
5600000 USD
us-gaap Defined Benefit Plan Interest Cost
DefinedBenefitPlanInterestCost
7000000.0 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
8800000 USD
us-gaap Defined Benefit Plan Expected Return On Plan Assets
DefinedBenefitPlanExpectedReturnOnPlanAssets
8900000 USD
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
-400000 USD
us-gaap Defined Benefit Plan Amortization Of Prior Service Cost Credit
DefinedBenefitPlanAmortizationOfPriorServiceCostCredit
-400000 USD
us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
0 USD
us-gaap Defined Benefit Plan Actuarial Gain Loss
DefinedBenefitPlanActuarialGainLoss
200000 USD
us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-3400000 USD
us-gaap Defined Benefit Plan Recognized Net Gain Loss Due To Settlements1
DefinedBenefitPlanRecognizedNetGainLossDueToSettlements1
-2700000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
800000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1300000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
800000 USD
us-gaap Defined Benefit Plan Net Periodic Benefit Cost
DefinedBenefitPlanNetPeriodicBenefitCost
1300000 USD
CY2020Q3 us-gaap Severance Costs1
SeveranceCosts1
4500000 USD
CY2019Q3 us-gaap Severance Costs1
SeveranceCosts1
600000 USD
us-gaap Severance Costs1
SeveranceCosts1
4500000 USD
us-gaap Severance Costs1
SeveranceCosts1
2200000 USD
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2019Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
100000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
100000 USD
CY2020Q3 us-gaap Other Restructuring Costs
OtherRestructuringCosts
0 USD
CY2019Q3 us-gaap Other Restructuring Costs
OtherRestructuringCosts
1100000 USD
us-gaap Other Restructuring Costs
OtherRestructuringCosts
0 USD
us-gaap Other Restructuring Costs
OtherRestructuringCosts
1500000 USD
CY2020Q3 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
4500000 USD
CY2019Q3 us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
1800000 USD
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
4500000 USD
us-gaap Restructuring And Related Cost Incurred Cost
RestructuringAndRelatedCostIncurredCost
3800000 USD
CY2020Q3 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
0 USD
CY2019Q3 us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
1000000.0 USD
us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
0 USD
us-gaap Foreign Currency Transaction Loss Before Tax
ForeignCurrencyTransactionLossBeforeTax
1000000.0 USD
CY2020Q3 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
900000 USD
CY2019Q3 us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
800000 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
7200000 USD
us-gaap Other Asset Impairment Charges
OtherAssetImpairmentCharges
2300000 USD
CY2020Q3 wst Development And Licensing Income
DevelopmentAndLicensingIncome
200000 USD
CY2019Q3 wst Development And Licensing Income
DevelopmentAndLicensingIncome
200000 USD
wst Development And Licensing Income
DevelopmentAndLicensingIncome
600000 USD
wst Development And Licensing Income
DevelopmentAndLicensingIncome
600000 USD
CY2020Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
800000 USD
CY2019Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
100000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
900000 USD
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
400000 USD
CY2020Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1000000.0 USD
CY2019Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-5100000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
4500000 USD
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
3500000 USD
CY2020Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
300000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.216
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10900000 USD
CY2019Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
2200000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1300000 USD
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
1800000 USD
CY2020Q3 wst Other Income Expense
OtherIncomeExpense
-6700000 USD
CY2019Q3 wst Other Income Expense
OtherIncomeExpense
-6400000 USD
wst Other Income Expense
OtherIncomeExpense
-6200000 USD
wst Other Income Expense
OtherIncomeExpense
-1600000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21100000 USD
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.168
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
52100000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
218500000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
2100000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1566700000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1369300000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42500000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.182
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.198
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
548000000.0 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
456100000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
99200000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
67300000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
290800000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-200000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
97700000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
2100000 USD
us-gaap Interest Expense
InterestExpense
6100000 USD
us-gaap Interest Expense
InterestExpense
6400000 USD
CY2020Q3 us-gaap Investment Income Net
InvestmentIncomeNet
200000 USD
CY2019Q3 us-gaap Investment Income Net
InvestmentIncomeNet
1000000.0 USD
us-gaap Investment Income Net
InvestmentIncomeNet
1200000 USD
us-gaap Investment Income Net
InvestmentIncomeNet
2500000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
400000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1300000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
300000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
64900000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
286200000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
214400000 USD

Files In Submission

Name View Source Status
0000105770-20-000057-index-headers.html Edgar Link pending
0000105770-20-000057-index.html Edgar Link pending
0000105770-20-000057.txt Edgar Link pending
0000105770-20-000057-xbrl.zip Edgar Link pending
ex10102020amendedresta.htm Edgar Link pending
ex311q32020.htm Edgar Link pending
ex312q32020.htm Edgar Link pending
ex321q32020.htm Edgar Link pending
ex322q32020.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
image011.jpg Edgar Link pending
image11.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wst-20200930.htm Edgar Link pending
wst-20200930.xsd Edgar Link pending
wst-20200930_cal.xml Edgar Link unprocessable
wst-20200930_def.xml Edgar Link unprocessable
wst-20200930_htm.xml Edgar Link completed
wst-20200930_lab.xml Edgar Link unprocessable
wst-20200930_pre.xml Edgar Link unprocessable